Preclinical pharmacokinetics, pharmacodynamics, and efficacy of RG7116: a novel humanized, glycoengineered anti-HER3 antibody
Crossref DOI link: https://doi.org/10.1007/s00280-015-2697-8
Published Online: 2015-02-22
Published Print: 2015-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Meneses-Lorente, Georgina
Friess, Thomas
Kolm, Irene
Hölzlwimmer, Gabriele
Bader, Sabine
Meille, Christophe
Thomas, Marlene
Bossenmaier, Birgit
License valid from 2015-02-22